
External Manufacturing and CMC leader with experience supporting antibody-drug conjugate (ADC) and other complex fermentation development programs through clinical manufacturing readiness. Proven track record managing global CDMO networks, coordinating complex manufacturing activities across drug substance, payload, conjugation, and drug product partners, and aligning cross-functional teams across Technical Operations, Quality, Regulatory, and Supply Chain. Experienced in building manufacturing strategies, governance structures, and risk mitigation frameworks that enable phase-appropriate CMC execution for complex biologics and small molecule programs.